JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on December 6, 2007; DOI: 10.1124/jpet.107.132134


0022-3565/08/3243-970-976$20.00
JPET 324:970-976, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.132134v1
324/3/970    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castello, P. R.
Right arrow Articles by Patel, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castello, P. R.
Right arrow Articles by Patel, M.

TOXICOLOGY

Inhibition of Mitochondrial Hydrogen Peroxide Production by Lipophilic Metalloporphyrins

Pablo R. Castello1, Derek A. Drechsel, Brian J. Day, and Manisha Patel

Department of Pharmaceutical Sciences, University of Colorado Health Sciences Center, Denver, Colorado (P.R.C., D.A.D., M.P.); and Department of Medicine, National Jewish Medical and Research Center, Denver, Colorado (B.J.D.)

Many studies have established a role for oxidative stress and mitochondrial dysfunction as an important mechanism in the pathogenesis of neuronal disorders. Metalloporphyrins are a class of catalytic antioxidants that are capable of detoxifying a wide range of reactive oxygen species. The AEOL112 series of glyoxylate metalloporphyrins were designed with increased lipid solubility for better oral bioavailability and penetration of the blood-brain barrier. The goal of this study was to develop an in vitro assay using rat brain mitochondria to reliably detect endogenously released hydrogen peroxide (H2O2) and identify glyoxylate metalloporphyrins based on rank order of potency for removal of physiologically relevant H2O2. A polarographic method was established for the sensitive, accurate, and reproducible detection of low levels of H2O2. The assay identified several potent glyoxylate metalloporphyrins with H2O2 scavenging potencies (IC50) in the nanomolar range. These results provide a simplified in vitro model system to detect physiologically generated mitochondrial H2O2 as a screening tool to predict the biological efficacy of potential therapeutic entities.


Received September 27, 2007; accepted December 5, 2007.

Address correspondence to: Dr. Manisha Patel, Department of Pharmaceutical Sciences, 4200 East Ninth Ave., School of Pharmacy, C238, Denver, CO 80262. E-mail: manisha.patel{at}uchsc.edu




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Zhou, H. G. Bohlen, S. J. Miller, and J. L. Unthank
NAD(P)H oxidase-derived peroxide mediates elevated basal and impaired flow-induced NO production in SHR mesenteric arteries in vivo
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1008 - H1016.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.